Clinical characteristics | E-group (n = 11) | Non-e-group (n = 19) | p |
---|---|---|---|
Sex | |||
Male | 7 | 8 | 0.449 |
Female | 4 | 11 | |
Age (years) | 52 (36.1–66) | 70 (46–86) | < 0.001 |
Associated comorbidities | 2 | 12 | 0.039 |
Serum carcinoembryonic antigen level (ng/mL) | 11.4 (1.0–369.0) | 8.0 (1.5–3498.0) | 0.726 |
Body mass index (kg/m2) | 23 (20.5–31) | 22.5 (19.6–30.5) | 0.776 |
Tumor characteristics | |||
Tumor size (cm) | 7.5 (3.0–11.0) | 7.5 (4.3–16.0) | 0.331 |
Cancer differentiation | |||
Moderately differentiated | 4 | 9 | 0.631 |
Poorly differentiated | 7 | 10 | |
Depth of cancer invasion | |||
T4a (serosa) | 3 | 2 | 0.327 |
T4b (adjacent organ) | 8 | 17 | |
Lymph node metastasis | 9 | 10 | 0.671 |
Dissected lymph node number | 19 (13–46) | 24 (15–69) | 0.294 |
Radicality | |||
R0 | 9 | 18 | 0.587 |
R1 | 2 | 1 |